Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer clinical trial (NCT06624878). Contact the study team or your healthcare provider for specific answers.

Question 2

How does esketamine compare to other treatments for managing depression after surgery?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer clinical trial (NCT06624878). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with esketamine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer clinical trial (NCT06624878). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my recovery be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer clinical trial (NCT06624878). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer clinical trial (NCT06624878). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there a chance I might receive the placebo instead of the actual medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer clinical trial (NCT06624878). Contact the study team or your healthcare provider for specific answers.

What this study is about